Alcohol Abuse Clinical Trial
Official title:
Telephone Disease Management At-Risk Drinking (TDM 11)
The aim of this study is to test for improvements in treatment outcomes for primary care
patients with at-risk drinking when cared for using telephone disease management (TDM)
compared to those treated with usual care. Based on our pilot data, TDM for at-risk drinking
may be a viable method for reducing alcohol consumption in this population.
Hypotheses: The hypotheses for this research plan are: 1. A significantly greater proportion
of patients assigned to TDM will obtain improvement in drinking outcomes compared to usual
care. 2. TDM will lead to greater access to behavioral health care and higher intensity of
treatment relative to usual care. This effect will be moderated by logistics such as
transportation problems, physical functioning, and employment status. 3. More patients
assigned to TDM will receive guideline adherent care.
We propose to randomize 200 patients with at-risk drinking from four primary care clinics at
the PVAMC and three Community Based Outpatient Clinics (CBOCs). Patients will be identified
for participation by 1. referrals from primary care clinicians based on existing screening
and clinical exams or 2. from the screening of a random subset of patients with an
appointment in the primary care clinic. A baseline assessment will establish eligibility for
participation in the study. The baseline assessment will also allow identification of those
patients who screen positive but do not have a definable behavioral health problem and those
with severe symptoms who may need more intensive help than provided by the study.
Consenting eligible patients will be randomly assigned to TDM or the lower intensity
intervention of usual care. For those patients assigned to usual care, the physician will
administer further evaluations and treatment as he/she sees fit. For those assigned to TDM,
the primary care provider remains the agent of treatment, but a Behavioral Health Specialist
(BHS) is made available to: maintain regularly scheduled telephone contact, develop a
treatment plan, monitor treatment effectiveness, assess and encourage treatment adherence,
and offer support and education. The role of the health specialist is defined by a treatment
manual that adheres to the recommendations of VA practice guidelines. TDM is based on a
chronic care model of treatment and includes a minimum of three BAI sessions. The health
specialist will communicate assessment information with the PCP in order to coordinate
treatment decisions.
The principal outcomes of the study relate to reduction in alcohol use within recommended
guidelines as well as access and utilization of behavioral health services over the course
of 12 months. Results favoring TDM may provide a low-cost, highly efficient mechanism for
integrating behavioral health with primary care for these patients. This project thus meets
several of the priority areas for HSR&D funding including improving access to care, the
implementation of practice guidelines, use of telemedicine, and patient-centered care.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03165942 -
Neuroendocrine Response to Oral Alcohol Administration
|
Phase 1 | |
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT03169244 -
Buproprion for Binge Drinking
|
Phase 2 | |
Recruiting |
NCT05246202 -
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
|
N/A | |
Completed |
NCT05036499 -
PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Not yet recruiting |
NCT04557631 -
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
|
||
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02681406 -
Smartphone Based Continuing Care for Alcohol
|
N/A | |
Completed |
NCT02448134 -
A Community-Based Strategy for Preventing Underage Drinking
|
N/A | |
Withdrawn |
NCT01796158 -
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Withdrawn |
NCT01511679 -
Brain-imaging and Adolescent Neuroscience Consortium
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Withdrawn |
NCT01275391 -
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT00907309 -
Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use
|
Phase 1/Phase 2 |